Evidence map›Paper›PMID 42326992›Full record

ArticlePain reports2026

Pirt promotes substance P release in cancer-induced bone pain.

Xueying Cheng, Zhonghua Zhang, Lan Zhou, Jingxiang Zeng, Chao Jiang, Shuo Cheng, Yuan Zhou, Guang Yu, Changming Wang

Abstract read
In one paragraph

Article in Pain reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xueying ChengSchool of Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Zhonghua ZhangSchool of Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Lan ZhouSchool of Traditional Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Jingxiang ZengSchool of Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Chao JiangSchool of Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Shuo ChengSchool of Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Yuan ZhouSchool of Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Guang YuSchool of Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Changming WangSchool of Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.ORCID https://orcid.org/0000-0002-8632-7666

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Cancer-induced bone pain (CIBP) is a major clinical challenge due to its intricate, poorly understood pathogenesis. Sensitized tumor-innervating nerves interacting with cancer cells drive CIBP, and substance P (SP) released by these nerves is a key mediator of pathological processes. However, the mechanisms regulating SP release in CIBP remain unclear. Objectives: To explore Pirt's involvement in CIBP and its role in regulating SP release. Methods: Molecular and behavioral experiments were performed using Pirt knockout (Pirt-KO) and wild-type (WT) mice in a CIBP model. Pain-related behaviors and SP were assessed, with Pirt expression and localization analyzed in dorsal root ganglia (DRG) and spinal cord. Results: Pirt-KO mice exhibited attenuated heat allodynia, mechanical allodynia, and spontaneous pain vs WT mice. Substance P level in tissues and SP release from DRG neurons was significantly reduced in Pirt-KO mice. All DRG SP-positive neurons expressed Pirt, and Pirt - green fluorescent protein (GFP) terminals projected to spinal lamina I/II, colocalizing with SP-positive terminals. Conclusion: Pirt plays a crucial role in promoting SP release in CIBP, shedding light on the molecular mechanisms underlying CIBP and providing a potential therapeutic target.

Indexed as

Cancer-induced bone painDRGPirtSubstance P

Identifiers

PMID42326992
PMCPMC13278241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.